These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 6814569)

  • 1. Decrease in pancreatic steatorrhoea by positioned-release enzyme capsules.
    Taylor RH; Mee AS; Misiewicz JJ; Barnardo DE; Polanska N
    Br Med J (Clin Res Ed); 1982 Nov; 285(6352):1392-3. PubMed ID: 6814569
    [No Abstract]   [Full Text] [Related]  

  • 2. Double-blind cross-over trial of an enzyme preparation in pancreatic steatorrhoea.
    Balakrishnan V; Hareendran A; Nair CS
    J Assoc Physicians India; 1981 Mar; 29(3):207-9. PubMed ID: 6912244
    [No Abstract]   [Full Text] [Related]  

  • 3. The ins and outs of oral pancreatic enzymes.
    Meyer JH
    N Engl J Med; 1977 Jun; 296(23):1347-8. PubMed ID: 859534
    [No Abstract]   [Full Text] [Related]  

  • 4. [Digestive action of acid-protected lipase in pancreatogenic steatorrhea].
    Brackmann P; Rüther HG
    Fortschr Med; 1984 Nov; 102(44):1143-5. PubMed ID: 6396183
    [No Abstract]   [Full Text] [Related]  

  • 5. Fate of oral enzymes in pancreatic insufficiency.
    Guarner L; Rodríguez R; Guarner F; Malagelada JR
    Gut; 1993 May; 34(5):708-12. PubMed ID: 8504976
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enteric coated microspheres of pancreatin in the treatment of cystic fibrosis: comparison with a standard enteric coated preparation.
    Stead RJ; Skypala I; Hodson ME; Batten JC
    Thorax; 1987 Jul; 42(7):533-7. PubMed ID: 3326213
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effect of an acid protected, micro-encapsulated pancreatin preparation on pancreatogenic steatorrhea].
    Kölbel C; Layer P; Hotz J; Goebell H
    Med Klin (Munich); 1986 Feb; 81(3):85-6. PubMed ID: 3641037
    [No Abstract]   [Full Text] [Related]  

  • 8. Pancreatic enzyme replacement therapy: comparative effects of conventional and enteric-coated microspheric pancreatin and acid-stable fungal enzyme preparations on steatorrhoea in chronic pancreatitis.
    Schneider MU; Knoll-Ruzicka ML; Domschke S; Heptner G; Domschke W
    Hepatogastroenterology; 1985 Apr; 32(2):97-102. PubMed ID: 2408983
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current concepts: pancreatic extracts.
    Littman A; Hanscom DH
    N Engl J Med; 1969 Jul; 281(4):201-4. PubMed ID: 4892805
    [No Abstract]   [Full Text] [Related]  

  • 10. Are minimicrosphere pancrelipase capsules effective enough for the treatment of pancreatic steatorrhea?
    Chung JP; Lee SJ; Park HJ; Lee KS; Chung JB; Lee SI; Kang JK
    Am J Gastroenterol; 2001 May; 96(5):1643-5. PubMed ID: 11374718
    [No Abstract]   [Full Text] [Related]  

  • 11. Symptomatic effect of pancreatic enzyme therapy in patients with chronic pancreatitis.
    Halgreen H; Pedersen NT; Worning H
    Scand J Gastroenterol; 1986 Jan; 21(1):104-8. PubMed ID: 3633631
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Efficacy of a new microencapsulated pancreatin versus a conventional preparation, in the treatment of steatorrhea of pancreatic origin].
    Aparisi L; Rodrigo JM; Serra MA; Del Olmo J; Bisquert M; Raga F
    Rev Esp Enferm Apar Dig; 1989 Jul; 76(1):25-30. PubMed ID: 2799034
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapy of pancreatogenic steatorrhoea: does acid protection of pancreatic enzymes offer any advantage?
    Lankisch PG; Lembcke B; Göke B; Creutzfeldt W
    Z Gastroenterol; 1986 Dec; 24(12):753-7. PubMed ID: 3548109
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fate of orally ingested enzymes in pancreatic insufficiency. Comparison of two dosage schedules.
    DiMagno EP; Malagelada JR; Go VL; Moertel CG
    N Engl J Med; 1977 Jun; 296(23):1318-22. PubMed ID: 16213
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of pancreatic exocrine insufficiency after pancreatic resection. Results of a randomized, double-blind, placebo-controlled, crossover study of high vs standard dose pancreatin.
    Neoptolemos JP; Ghaneh P; Andrén-Sandberg A; Bramhall S; Patankar R; Kleibeuker JH; Johnson CD
    Int J Pancreatol; 1999 Jun; 25(3):171-80. PubMed ID: 10453419
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Therapy of pancreatogenic steatorrhea. Comparison of 2 acid-protected enzyme preparations].
    Lankisch PG; Lembcke B; Kirchhoff S; Hilgers R; Creutzfeldt W
    Dtsch Med Wochenschr; 1988 Jan; 113(1):15-7. PubMed ID: 3335192
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Omeprazole enhances the efficacy of pancreatin (pancrease) in cystic fibrosis.
    Heijerman HG; Lamers CB; Bakker W
    Ann Intern Med; 1991 Feb; 114(3):200-1. PubMed ID: 1984743
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nutrizym as a pancreatic enzyme replacement.
    Moshal MG
    S Afr Med J; 1974 Jul; 48(35):1489-90. PubMed ID: 4604836
    [No Abstract]   [Full Text] [Related]  

  • 19. [The effect and tolerance of a gall-enzyme preparation].
    Gross W; Kaiser HJ
    Med Welt; 1978 Jan; 29(4):144-9. PubMed ID: 345040
    [No Abstract]   [Full Text] [Related]  

  • 20. Drug-nutrient interactions: use of Cimetidine in malabsorption syndromes.
    Nutr Rev; 1978 May; 36(5):146-7. PubMed ID: 355947
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.